Chemoinformaics analysis of (E)-16-HYDROXYHEXADEC-7-ENOIC ACID
| Molecular Weight | 270.413 | nRot | 14 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 8 |
| Exact Molecular Weight | 270.219 | nRing | 0 |
| Solubility: LogS | -1.184 | nHRing | 0 |
| Solubility: LogP | 0.281 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 49.1298 |
| nHD | 2 | BPOL | 30.9642 |
| QED | 0.417 |
| Synth | 2.355 |
| Natural Product Likeliness | 0.585 |
| NR-PPAR-gamma | 0.171 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.482 |
| MDCK | 0.0000219 |
| BBB | 0.98 |
| PPB | 0.881964 |
| VDSS | 1.556 |
| FU | 0.0696506 |
| CYP1A2-inh | 0.28 |
| CYP1A2-sub | 0.146 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.383 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.092 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.268 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.211 |
| CL | 4.034 |
| T12 | 0.931 |
| hERG | 0.004 |
| Ames | 0.131 |
| ROA | 0.903 |
| SkinSen | 0.956 |
| Carcinogencity | 0.775 |
| EI | 0.983 |
| Respiratory | 0.98 |
| NR-Aromatase | 0.649 |
| Antiviral | Yes |
| Prediction | 0.685206 |